Overcoming the Interobserver Variability in Lung Adenocarcinoma Subtyping

Author:

Lami Kris1,Bychkov Andrey2,Matsumoto Keitaro3,Attanoos Richard4,Berezowska Sabina5,Brcic Luka6,Cavazza Alberto7,English John C.8,Fabro Alexandre Todorovic9,Ishida Kaori10,Kashima Yukio11,Larsen Brandon T.12,Marchevsky Alberto M.13,Miyazaki Takuro3,Morimoto Shimpei14,Roden Anja C.15,Schneider Frank16,Soshi Mano17,Smith Maxwell L.12,Tabata Kazuhiro18,Takano Angela M.19,Tanaka Kei20,Tanaka Tomonori1,Tsuchiya Tomoshi3,Nagayasu Takeshi3,Fukuoka Junya1

Affiliation:

1. From the Department of Pathology (Lami, K. Tanaka, Fukuoka), Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

2. The Department of Pathology, Kameda Medical Center, Kamogawa, Japan (Bychkov)

3. Department of Surgical Oncology (Matsumoto, Miyazaki, Tsuchiya, Nagayasu), Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

4. The Department of Cellular Pathology, Cardiff University, Cardiff, United Kingdom (Attanoos)

5. The Institute of Pathology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland (Berezowska)

6. The Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria (Brcic)

7. The Unit of Pathologic Anatomy, Azienda USL/IRCCS di Reggio Emilia, Reggio Emilia, Italy (Cavazza)

8. The Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada (English)

9. The Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil (Fabro)

10. The Department of Pathology, Kansai Medical University, Osaka, Japan (Ishida)

11. The Department of Pathology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan (Kashima)

12. The Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Larsen, Smith)

13. The Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, California (Marchevsky)

14. The Innovation Platform & Office for Precision Medicine (Morimoto), Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

15. The Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Roden)

16. The Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia (Schneider)

17. BonBon Co, Ltd, Kyoto, Japan (Soshi)

18. The Department of Pathology, Kagoshima University, Kagoshima, Japan (Tabata)

19. The Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore (Takano)

20. The Department of Diagnostic Pathology, Kobe University Hospital, Kobe, Japan (T. Tanaka)

Abstract

Context.— The accurate identification of different lung adenocarcinoma histologic subtypes is important for determining prognosis but can be challenging because of overlaps in the diagnostic features, leading to considerable interobserver variability. Objective.— To provide an overview of the diagnostic agreement for lung adenocarcinoma subtypes among pathologists and to create a ground truth using the clustering approach for downstream computational applications. Design.— Three sets of lung adenocarcinoma histologic images with different evaluation levels (small patches, areas with relatively uniform histology, and whole slide images) were reviewed by 18 international expert lung pathologists. Each image was classified into one or several lung adenocarcinoma subtypes. Results.— Among the 4702 patches of the first set, 1742 (37%) had an overall consensus among all pathologists. The overall Fleiss κ score for the agreement of all subtypes was 0.58. Using cluster analysis, pathologists were hierarchically grouped into 2 clusters, with κ scores of 0.588 and 0.563 in clusters 1 and 2, respectively. Similar results were obtained for the second and third sets, with fair-to-moderate agreements. Patches from the first 2 sets that obtained the consensus of the 18 pathologists were retrieved to form consensus patches and were regarded as the ground truth of lung adenocarcinoma subtypes. Conclusions.— Our observations highlight discrepancies among experts when assessing lung adenocarcinoma subtypes. However, a subsequent number of consensus patches could be retrieved from each cluster, which can be used as ground truth for the downstream computational pathology applications, with minimal influence from interobserver variability.

Publisher

Archives of Pathology and Laboratory Medicine

Subject

Medical Laboratory Technology,General Medicine,Pathology and Forensic Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3